CA2586022A1 - Appareil et procede de traitement par ablation guidee - Google Patents
Appareil et procede de traitement par ablation guidee Download PDFInfo
- Publication number
- CA2586022A1 CA2586022A1 CA002586022A CA2586022A CA2586022A1 CA 2586022 A1 CA2586022 A1 CA 2586022A1 CA 002586022 A CA002586022 A CA 002586022A CA 2586022 A CA2586022 A CA 2586022A CA 2586022 A1 CA2586022 A1 CA 2586022A1
- Authority
- CA
- Canada
- Prior art keywords
- guide member
- ablation
- tissue
- heart
- lesion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 49
- 238000011298 ablation treatment Methods 0.000 title description 2
- 210000002216 heart Anatomy 0.000 claims abstract description 95
- 238000002679 ablation Methods 0.000 claims abstract description 76
- 230000003902 lesion Effects 0.000 claims abstract description 68
- 230000007246 mechanism Effects 0.000 claims abstract description 7
- 230000037361 pathway Effects 0.000 claims abstract description 7
- 239000000835 fiber Substances 0.000 claims description 73
- 210000001519 tissue Anatomy 0.000 claims description 59
- 210000005003 heart tissue Anatomy 0.000 claims description 19
- 239000013307 optical fiber Substances 0.000 claims description 11
- 239000012809 cooling fluid Substances 0.000 claims description 8
- 230000001427 coherent effect Effects 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 5
- 230000033001 locomotion Effects 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 125000006850 spacer group Chemical group 0.000 claims description 2
- 206010003658 Atrial Fibrillation Diseases 0.000 abstract description 23
- 230000015572 biosynthetic process Effects 0.000 abstract description 15
- 230000001746 atrial effect Effects 0.000 abstract description 10
- 238000011065 in-situ storage Methods 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 description 28
- 210000003748 coronary sinus Anatomy 0.000 description 11
- 210000004165 myocardium Anatomy 0.000 description 10
- 238000000608 laser ablation Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000002107 myocardial effect Effects 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- 238000001816 cooling Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 210000003492 pulmonary vein Anatomy 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000002837 heart atrium Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 238000003763 carbonization Methods 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 4
- 210000000115 thoracic cavity Anatomy 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 230000007831 electrophysiology Effects 0.000 description 3
- 238000002001 electrophysiology Methods 0.000 description 3
- 238000010304 firing Methods 0.000 description 3
- 238000013021 overheating Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000007493 shaping process Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000013130 cardiovascular surgery Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000007674 radiofrequency ablation Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004901 spalling Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
- 229920004943 Delrin® Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- 210000001992 atrioventricular node Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000002681 cryosurgery Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000011304 dilated cardiomyopathy 1A Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Landscapes
- Laser Surgery Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/975,674 US7267674B2 (en) | 2003-10-30 | 2004-10-28 | Apparatus and method for laser treatment |
| US10/975,674 | 2004-10-28 | ||
| US11/102,091 US7238179B2 (en) | 2003-10-30 | 2005-04-08 | Apparatus and method for guided ablation treatment |
| US11/102,091 | 2005-04-08 | ||
| PCT/US2005/038715 WO2006050011A1 (fr) | 2003-10-30 | 2005-10-25 | Appareil et procede de traitement par ablation guidee |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2586022A1 true CA2586022A1 (fr) | 2006-05-11 |
Family
ID=56290746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002586022A Abandoned CA2586022A1 (fr) | 2004-10-28 | 2005-10-25 | Appareil et procede de traitement par ablation guidee |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1827276A1 (fr) |
| JP (1) | JP2008518661A (fr) |
| AU (1) | AU2005302563A1 (fr) |
| CA (1) | CA2586022A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015123163A1 (fr) * | 2014-02-11 | 2015-08-20 | St. Jude Medical, Cardiology Division, Inc. | Cathéter d'ablation et procédés associés |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008058148B4 (de) * | 2008-11-20 | 2010-07-08 | Vimecon Gmbh | Laserapplikator |
| EP4385445A2 (fr) * | 2016-11-22 | 2024-06-19 | Dominion Aesthetic Technologies, Inc. | Appareil et procédés de refroidissement par impact |
| US10994151B2 (en) | 2016-11-22 | 2021-05-04 | Dominion Aesthetic Technologies, Inc. | Systems and methods for aesthetic treatment |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020087151A1 (en) * | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
-
2005
- 2005-10-25 AU AU2005302563A patent/AU2005302563A1/en not_active Abandoned
- 2005-10-25 EP EP05824352A patent/EP1827276A1/fr not_active Withdrawn
- 2005-10-25 CA CA002586022A patent/CA2586022A1/fr not_active Abandoned
- 2005-10-25 JP JP2007539094A patent/JP2008518661A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015123163A1 (fr) * | 2014-02-11 | 2015-08-20 | St. Jude Medical, Cardiology Division, Inc. | Cathéter d'ablation et procédés associés |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008518661A (ja) | 2008-06-05 |
| AU2005302563A1 (en) | 2006-05-11 |
| EP1827276A1 (fr) | 2007-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7238179B2 (en) | Apparatus and method for guided ablation treatment | |
| US7238180B2 (en) | Guided ablation with end-fire fiber | |
| US7232437B2 (en) | Assessment of lesion transmurality | |
| US7267674B2 (en) | Apparatus and method for laser treatment | |
| US11304748B2 (en) | Cardiac treatment devices and methods | |
| US6579285B2 (en) | Photoablation with infrared radiation | |
| US6849075B2 (en) | Cardiac ablation devices and methods | |
| US7731715B2 (en) | Ablative treatment of atrial fibrillation via the coronary sinus | |
| US20040167503A1 (en) | Malleable surgical ablation instruments | |
| EP0934728A2 (fr) | Traitement sélectif de la couche limite endocardiale/myocardiale | |
| JPH1033550A (ja) | レーザ活用経心筋血管再生および他の用途のための深さ止め装置および方法 | |
| US20070073278A1 (en) | Cardiac Ablation Dosing | |
| CA2586022A1 (fr) | Appareil et procede de traitement par ablation guidee | |
| US20070073277A1 (en) | Controlled guided ablation treatment | |
| US20070073281A1 (en) | Guided ablation with motion control | |
| US20070073280A1 (en) | End-fire guided ablation | |
| AU9409698A (en) | Selective treatment of endocardial/myocardial boundary |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |